Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
Accendra Health, Inc. has scheduled the release of its third-quarter 2026 financial results for November 5, 2026, to be followed by an investor conference call.
Stocks · News reference
Accendra Health Names Kenneth Gardner-Smith as Next President and CEO; Expected To Assume the Role Early in Q4 of 2026, succeeding Edward Pesicka
Chief Commercial OfficerAccendra Health also today named Scott Lloyd to the role of Chief Commercial Officer, effective October 5, 2026. The Company created the position to bring commercial strategy, sales, and provider
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — ACCENDRA HEALTH INC/VA/ (ACH)
Filed: 2026-10-09 AccNo: 0001104659-26-115043 Size: 184 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Accendra Health Says It Received NYSE Notice Over $1.00 Minimum Share Price Rule; Will Consider Reverse Split If Necessary
Accendra Health Form 13G Shows Bank Of America Reports 10.8% Stake In Co. As Of Sept. 30
https://www.sec.gov/Archives/edgar/data/70858/000007085826000476/xslSCHEDULE_13G_X02/primary_doc.xml